nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G4A—amyotrophic lateral sclerosis	0.762	1	CbGaD
Suramin—P2RX4—peripheral nervous system—amyotrophic lateral sclerosis	0.00987	0.0884	CbGeAlD
Suramin—FSHR—hindbrain—amyotrophic lateral sclerosis	0.00927	0.0831	CbGeAlD
Suramin—P2RX4—nerve—amyotrophic lateral sclerosis	0.00769	0.0689	CbGeAlD
Suramin—SIRT1—nerve—amyotrophic lateral sclerosis	0.00674	0.0604	CbGeAlD
Suramin—F2—forelimb—amyotrophic lateral sclerosis	0.00651	0.0584	CbGeAlD
Suramin—F2—hindlimb—amyotrophic lateral sclerosis	0.00586	0.0525	CbGeAlD
Suramin—F2—appendage—amyotrophic lateral sclerosis	0.00503	0.045	CbGeAlD
Suramin—PLA2G2A—tongue—amyotrophic lateral sclerosis	0.00461	0.0413	CbGeAlD
Suramin—FSHR—cerebellum—amyotrophic lateral sclerosis	0.00262	0.0235	CbGeAlD
Suramin—SIRT5—medulla oblongata—amyotrophic lateral sclerosis	0.00243	0.0218	CbGeAlD
Suramin—P2RX4—medulla oblongata—amyotrophic lateral sclerosis	0.0023	0.0206	CbGeAlD
Suramin—P2RX4—spinal cord—amyotrophic lateral sclerosis	0.00205	0.0184	CbGeAlD
Suramin—SIRT1—medulla oblongata—amyotrophic lateral sclerosis	0.00202	0.0181	CbGeAlD
Suramin—RYR1—medulla oblongata—amyotrophic lateral sclerosis	0.00186	0.0167	CbGeAlD
Suramin—SIRT5—nervous system—amyotrophic lateral sclerosis	0.00183	0.0164	CbGeAlD
Suramin—SIRT1—spinal cord—amyotrophic lateral sclerosis	0.0018	0.0161	CbGeAlD
Suramin—ARSA—spinal cord—amyotrophic lateral sclerosis	0.00178	0.0159	CbGeAlD
Suramin—SIRT5—central nervous system—amyotrophic lateral sclerosis	0.00176	0.0158	CbGeAlD
Suramin—P2RX4—nervous system—amyotrophic lateral sclerosis	0.00173	0.0155	CbGeAlD
Suramin—SIRT5—cerebellum—amyotrophic lateral sclerosis	0.00172	0.0154	CbGeAlD
Suramin—P2RX4—central nervous system—amyotrophic lateral sclerosis	0.00167	0.0149	CbGeAlD
Suramin—P2RX4—cerebellum—amyotrophic lateral sclerosis	0.00163	0.0146	CbGeAlD
Suramin—SIRT1—nervous system—amyotrophic lateral sclerosis	0.00152	0.0136	CbGeAlD
Suramin—ARSA—nervous system—amyotrophic lateral sclerosis	0.0015	0.0134	CbGeAlD
Suramin—SIRT1—central nervous system—amyotrophic lateral sclerosis	0.00146	0.0131	CbGeAlD
Suramin—ARSA—central nervous system—amyotrophic lateral sclerosis	0.00144	0.0129	CbGeAlD
Suramin—SIRT1—cerebellum—amyotrophic lateral sclerosis	0.00143	0.0128	CbGeAlD
Suramin—ARSA—cerebellum—amyotrophic lateral sclerosis	0.00141	0.0126	CbGeAlD
Suramin—RYR1—nervous system—amyotrophic lateral sclerosis	0.0014	0.0126	CbGeAlD
Suramin—SIRT5—brain—amyotrophic lateral sclerosis	0.0014	0.0125	CbGeAlD
Suramin—RYR1—central nervous system—amyotrophic lateral sclerosis	0.00135	0.0121	CbGeAlD
Suramin—P2RX4—brain—amyotrophic lateral sclerosis	0.00132	0.0118	CbGeAlD
Suramin—RYR1—cerebellum—amyotrophic lateral sclerosis	0.00132	0.0118	CbGeAlD
Suramin—SIRT1—brain—amyotrophic lateral sclerosis	0.00116	0.0104	CbGeAlD
Suramin—ARSA—brain—amyotrophic lateral sclerosis	0.00114	0.0103	CbGeAlD
Suramin—RYR1—brain—amyotrophic lateral sclerosis	0.00107	0.00959	CbGeAlD
Suramin—PLA2G2A—nervous system—amyotrophic lateral sclerosis	0.00106	0.00951	CbGeAlD
Suramin—PLA2G2A—central nervous system—amyotrophic lateral sclerosis	0.00102	0.00916	CbGeAlD
Suramin—PLA2G4A—medulla oblongata—amyotrophic lateral sclerosis	0.000982	0.0088	CbGeAlD
Suramin—F2—spinal cord—amyotrophic lateral sclerosis	0.000951	0.00852	CbGeAlD
Suramin—PLA2G4A—spinal cord—amyotrophic lateral sclerosis	0.000876	0.00785	CbGeAlD
Suramin—PLA2G2A—brain—amyotrophic lateral sclerosis	0.000811	0.00727	CbGeAlD
Suramin—F2—nervous system—amyotrophic lateral sclerosis	0.000801	0.00718	CbGeAlD
Suramin—F2—central nervous system—amyotrophic lateral sclerosis	0.000771	0.00691	CbGeAlD
Suramin—PLA2G4A—nervous system—amyotrophic lateral sclerosis	0.000738	0.00661	CbGeAlD
Suramin—PLA2G4A—central nervous system—amyotrophic lateral sclerosis	0.00071	0.00637	CbGeAlD
Suramin—F2—brain—amyotrophic lateral sclerosis	0.000612	0.00549	CbGeAlD
Suramin—PLA2G4A—brain—amyotrophic lateral sclerosis	0.000564	0.00506	CbGeAlD
Suramin—F2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.000359	0.00283	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000355	0.0028	CbGpPWpGaD
Suramin—ARSA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000348	0.00275	CbGpPWpGaD
Suramin—ARSA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000348	0.00275	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000344	0.00272	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—CASP9—amyotrophic lateral sclerosis	0.000339	0.00268	CbGpPWpGaD
Suramin—F2—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000332	0.00263	CbGpPWpGaD
Suramin—F2—IL1 and megakaryotyces in obesity—MMP9—amyotrophic lateral sclerosis	0.000331	0.00262	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000325	0.00256	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.000324	0.00256	CbGpPWpGaD
Suramin—PLA2G2A—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000321	0.00254	CbGpPWpGaD
Suramin—ARSA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000318	0.00252	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000317	0.0025	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000317	0.0025	CbGpPWpGaD
Suramin—PLA2G4A—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.000306	0.00242	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—SOD1—amyotrophic lateral sclerosis	0.000304	0.0024	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000302	0.00238	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000302	0.00238	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000299	0.00236	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000296	0.00234	CbGpPWpGaD
Suramin—ARSA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000296	0.00234	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000296	0.00234	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.00029	0.0023	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000289	0.00229	CbGpPWpGaD
Suramin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000289	0.00228	CbGpPWpGaD
Suramin—F2—Complement and Coagulation Cascades—C3—amyotrophic lateral sclerosis	0.000288	0.00228	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000282	0.00223	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000278	0.0022	CbGpPWpGaD
Suramin—ARSA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000278	0.0022	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000276	0.00218	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000266	0.0021	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000265	0.0021	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000264	0.00209	CbGpPWpGaD
Suramin—F2—Syndecan-4-mediated signaling events—MMP9—amyotrophic lateral sclerosis	0.000263	0.00208	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000262	0.00207	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000262	0.00207	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.000259	0.00205	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000259	0.00204	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000256	0.00203	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—amyotrophic lateral sclerosis	0.000255	0.00202	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000253	0.002	CbGpPWpGaD
Suramin—ARSA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000252	0.00199	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000251	0.00198	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000239	0.00189	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000238	0.00188	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000237	0.00188	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000234	0.00185	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00023	0.00181	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000224	0.00177	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000224	0.00177	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000224	0.00177	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000223	0.00176	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000217	0.00172	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000217	0.00172	CbGpPWpGaD
Suramin—F2—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000216	0.00171	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000211	0.00167	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000209	0.00165	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000205	0.00162	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000205	0.00162	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000205	0.00162	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000205	0.00162	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000202	0.0016	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000202	0.00159	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000199	0.00157	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000198	0.00156	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000195	0.00154	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000194	0.00153	CbGpPWpGaD
Suramin—PLA2G4A—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000192	0.00152	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000191	0.00151	CbGpPWpGaD
Suramin—ARSA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000191	0.00151	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.00019	0.0015	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00019	0.0015	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000187	0.00148	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000185	0.00146	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000185	0.00146	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00018	0.00142	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.00018	0.00142	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000179	0.00142	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000179	0.00141	CbGpPWpGaD
Suramin—ARSA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000176	0.00139	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000174	0.00138	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000174	0.00137	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00017	0.00134	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000168	0.00133	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000165	0.0013	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000162	0.00128	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00016	0.00127	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00016	0.00126	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000159	0.00126	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000154	0.00122	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000153	0.00121	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000152	0.0012	CbGpPWpGaD
Suramin—F2—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00015	0.00118	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000145	0.00114	CbGpPWpGaD
Suramin—ARSA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000145	0.00114	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.000143	0.00113	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000142	0.00112	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00014	0.00111	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00014	0.00111	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000139	0.0011	CbGpPWpGaD
Suramin—F2—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000139	0.0011	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000137	0.00108	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000137	0.00108	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000136	0.00107	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.000135	0.00107	CbGpPWpGaD
Suramin—F2—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000135	0.00107	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000134	0.00106	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000132	0.00105	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000132	0.00104	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00013	0.00103	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000127	0.00101	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000126	0.000999	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000123	0.000974	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000123	0.000971	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000122	0.000965	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000122	0.000964	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.000118	0.000933	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000118	0.000931	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000117	0.000928	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000116	0.000914	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000116	0.000913	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000114	0.000903	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000113	0.000896	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.000896	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.000896	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000113	0.000894	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000111	0.000876	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00011	0.000872	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000106	0.000835	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000106	0.000835	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000104	0.00082	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000816	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.0001	0.000792	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.0001	0.000791	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.0001	0.000791	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.85e-05	0.000779	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—VAPA—amyotrophic lateral sclerosis	9.67e-05	0.000764	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.65e-05	0.000762	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	9.42e-05	0.000744	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.32e-05	0.000736	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CHAT—amyotrophic lateral sclerosis	9.32e-05	0.000736	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.05e-05	0.000715	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.04e-05	0.000714	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.99e-05	0.00071	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	8.92e-05	0.000705	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.74e-05	0.00069	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.62e-05	0.000681	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.5e-05	0.000672	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—FIG4—amyotrophic lateral sclerosis	8.45e-05	0.000668	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.32e-05	0.000658	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	7.92e-05	0.000626	CbGpPWpGaD
Suramin—ARSA—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.77e-05	0.000614	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	7.71e-05	0.000609	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DAO—amyotrophic lateral sclerosis	7.64e-05	0.000604	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	7.59e-05	0.000599	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	7.48e-05	0.000591	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	7.4e-05	0.000584	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.38e-05	0.000583	CbGpPWpGaD
Suramin—ARSA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.14e-05	0.000564	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.12e-05	0.000563	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	7.05e-05	0.000557	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.94e-05	0.000548	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	6.79e-05	0.000537	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.7e-05	0.000529	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	6.57e-05	0.000519	CbGpPWpGaD
Suramin—F2—Hemostasis—SOD1—amyotrophic lateral sclerosis	6.52e-05	0.000515	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	6.21e-05	0.000491	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.13e-05	0.000484	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.1e-05	0.000482	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SOD1—amyotrophic lateral sclerosis	5.96e-05	0.000471	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.92e-05	0.000468	CbGpPWpGaD
Suramin—ARSA—Metabolism—APOE—amyotrophic lateral sclerosis	5.87e-05	0.000464	CbGpPWpGaD
Suramin—F2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	5.85e-05	0.000462	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.82e-05	0.00046	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PLB1—amyotrophic lateral sclerosis	5.79e-05	0.000458	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	5.78e-05	0.000456	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.71e-05	0.000451	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.51e-05	0.000435	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSR—amyotrophic lateral sclerosis	5.34e-05	0.000422	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	5.29e-05	0.000418	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.18e-05	0.000409	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.04e-05	0.000398	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.01e-05	0.000396	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	4.98e-05	0.000393	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	4.84e-05	0.000383	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	4.72e-05	0.000373	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.71e-05	0.000373	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	4.61e-05	0.000364	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.6e-05	0.000364	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	4.57e-05	0.000361	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.55e-05	0.00036	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	4.55e-05	0.00036	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CHAT—amyotrophic lateral sclerosis	4.39e-05	0.000347	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	4.32e-05	0.000341	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	4.18e-05	0.00033	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.06e-05	0.000321	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.02e-05	0.000318	CbGpPWpGaD
Suramin—F2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.01e-05	0.000317	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4e-05	0.000316	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.97e-05	0.000314	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.91e-05	0.000309	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOE—amyotrophic lateral sclerosis	3.79e-05	0.000299	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.71e-05	0.000293	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.67e-05	0.00029	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.63e-05	0.000287	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.63e-05	0.000287	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.51e-05	0.000277	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.43e-05	0.000271	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.35e-05	0.000265	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.31e-05	0.000262	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.26e-05	0.000258	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	3.13e-05	0.000247	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.08e-05	0.000243	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.97e-05	0.000235	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.96e-05	0.000234	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.76e-05	0.000218	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.74e-05	0.000217	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.71e-05	0.000214	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.6e-05	0.000205	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.59e-05	0.000205	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.59e-05	0.000204	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.52e-05	0.000199	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.46e-05	0.000195	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.37e-05	0.000188	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.36e-05	0.000187	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.36e-05	0.000186	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.33e-05	0.000184	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.25e-05	0.000178	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.25e-05	0.000178	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.11e-05	0.000167	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	0.000157	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—amyotrophic lateral sclerosis	1.96e-05	0.000155	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.93e-05	0.000152	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.79e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOE—amyotrophic lateral sclerosis	1.78e-05	0.000141	CbGpPWpGaD
Suramin—F2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.75e-05	0.000138	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.63e-05	0.000129	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.6e-05	0.000127	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.49e-05	0.000118	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.35e-05	0.000106	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.23e-05	9.74e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.22e-05	9.66e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.04e-05	8.19e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.8e-06	7.74e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.49e-06	7.49e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.96e-06	7.08e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.8e-06	6.95e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.05e-06	6.36e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.65e-06	5.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.08e-06	4.81e-05	CbGpPWpGaD
